The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam

<p>Abstract</p> <p>Background</p> <p>In Vietnam, the artemisinin-based combination therapy (ACT) of dihydroartemisinin-piperaquine is currently used for first-line treatment of uncomplicated <it>Plasmodium falciparum</it> malaria. However, limited efficacy a...

Full description

Bibliographic Details
Published in:	Malaria Journal
Main Authors:	Thanh Nguyen, Trung Trieu, Phong Nguyen, Quang Huynh, Dai Bui, Shanks G, Chavchich Marina, Edstein Michael D
Format:	Article
Language:	English
Published:	BMC 2012-06-01
Subjects:	Malaria <it>Plasmodium falciparum</it> Artemisinin Piperaquine Artesunate Amodiaquine
Online Access:	http://www.malariajournal.com/content/11/1/217

Similar Items

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
by: Celine I. Mandara, et al.
Published: (2019-03-01)

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
by: Abel Nhama, et al.
Published: (2025-07-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance
by: Mahamat Souleymane Issa, et al.
Published: (2023-08-01)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
by: Oméga Raobela, et al.
Published: (2018-08-01)

Artesunate-amodiaquine fixed dose combination for the treatment of <it>Plasmodium falciparum </it>malaria in India
by: Anvikar Anupkumar R, et al.
Published: (2012-03-01)

Efficacy of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children aged 2–11 years in the Asante Akim North Municipality, Ghana: a single-arm open trial
by: Henry Hanson, et al.
Published: (2025-10-01)

Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats
by: Xiaobo Li, et al.
Published: (2022-10-01)

Effectiveness and safety of artesunate–amodiaquine versus artemether–lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6–120 months in Yaoundé, Cameroon: a randomized trial
by: Peter Thelma Ngwa Niba, et al.
Published: (2022-02-01)

Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar
by: Irinantenaina Judickaëlle, et al.
Published: (2023-01-01)

Meta-Analysis of Data from Four Clinical Trials in the Ivory Coast Assessing the Efficacy of Two Artemisinin-Based Combination Therapies (Artesunate-Amodiaquine and Artemether-Lumefantrine) between 2009 and 2016
by: Akoua Valérie Bédia-Tanoh, et al.
Published: (2023-12-01)

Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial
by: Abdoul Habib Beavogui, et al.
Published: (2020-06-01)

Efficacy and safety of artemisinin-naphthoquine <it>versus</it> dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
by: Tjitra Emiliana, et al.
Published: (2012-06-01)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
by: Bui Quang Phuc, et al.
Published: (2017-04-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017
by: Benjamin Abuaku, et al.
Published: (2019-06-01)

Lack of selection of antimalarial drug resistance markers after intermittent preventive treatment of schoolchildren (IPTsc) against malaria in northeastern Tanzania
by: Frederik Von Wowern, et al.
Published: (2024-09-01)

Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial
by: Kristin Banek, et al.
Published: (2018-06-01)

Efficacy of fixed-dose combination artesunate-amodiaquine <it>versus</it> artemether-lumefantrine for uncomplicated childhood <it>Plasmodium falciparum</it> malaria in Democratic Republic of Congo: a randomized non-inferiority trial
by: Espié Emmanuelle, et al.
Published: (2012-05-01)

Early effects of concurrent administration of artesunate-amodiaquine and nifedipine on sperm parameters and sex hormones in guinea pigs: An experimental study
by: Jonah Sydney Aprioku
Published: (2018-10-01)

The Effects of Frequent Therapeutic Administration of Artesunate-amodiaquine and Artemether-lumefantrine on Haematological Markers in BALB/c Mice
by: David Audu, et al.
Published: (2023-03-01)

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria among children 6–59 months in three sentinel sites of Sierra Leone, 2021–2022
by: Irene Cavros, et al.
Published: (2026-04-01)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
by: Angana Mukherjee, et al.
Published: (2017-05-01)

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
by: Alphonse Ouédraogo, et al.
Published: (2024-12-01)

Xylopic acid-amodiaquine and xylopic acid-artesunate combinations are effective in managing malaria in Plasmodium berghei-infected mice
by: Silas Acheampong Osei, et al.
Published: (2021-02-01)

The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
by: Agnandji Selidji T, et al.
Published: (2011-12-01)

A non-randomized, open-label study to assess the impact of rounds of mass drug administration with artemisinin-piperaquine plus primaquine on malaria in São Tomé Island
by: Mingqiang Li, et al.
Published: (2025-05-01)

Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment
by: Habtemikael L, et al.
Published: (2020-11-01)

Decreased prevalence of <it>Plasmodium falciparum</it> resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar
by: Fröberg Gabrielle, et al.
Published: (2012-09-01)

Efikasi Obat Kloroquine, Kina, Artesunate-SP, Artesunate-Amodiaquine, Artesunate-Lumafentrin pada Anak Malaria Falciparum di BLU RSUP Prof. Dr. RD. Kandou Manado
by: Suryadi Nicolaas Napoleon Tatura
Published: (2016-11-01)

Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo
by: Brice Pembet Singana, et al.
Published: (2022-05-01)

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
by: Francesco Grandesso, et al.
Published: (2018-01-01)

Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved]
by: Peter Mwitari, et al.
Published: (2023-10-01)

A campaign of mass drug administration with artemisinin-piperaquine to antimalaria in Trobriand Islands
by: Guoming Li, et al.
Published: (2023-04-01)

Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials
by: Dawit Getachew Assefa, et al.
Published: (2021-08-01)

Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam
by: Nguyen Chinh Phong, et al.
Published: (2019-01-01)

No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
by: Fang Huang, et al.
Published: (2020-09-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea
by: Livingstone Tavul, et al.
Published: (2018-10-01)

High efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania
by: Celine I. Mandara, et al.
Published: (2018-07-01)

Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01)

Artemisinin and Its Derivatives as Potential Anticancer Agents
by: Luan Wen, et al.
Published: (2024-08-01)